alphaCT-11

N/A

Report date: 2025/01/26 18:34:45

Base Information

Drug NamealphaCT-11
Drug Alias NamealphaCT-1 variant (Fralin Biomedical Research Institute)
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Exosomes
Mechanisms of ActionGap junction alpha-1 protein modulators
TargetsGap junction alpha-1 protein
Therapy Area/IndicationsHeart InjuriesMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHeart InjuriesMyocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A